Rayonier Advanced Materials Enters Material Definitive Agreement

TL;DR

RYAM signed a big deal, details to come.

AI Summary

Rayonier Advanced Materials Inc. (RYAM) announced on November 12, 2024, that it entered into a Material Definitive Agreement. The filing also includes Regulation FD disclosures and financial statements, with specific details on the agreement not provided in this excerpt.

Why It Matters

This filing indicates a significant new contract or partnership for Rayonier Advanced Materials, which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, but the lack of specific details about the terms and implications introduces uncertainty.

Key Players & Entities

• Rayonier Advanced Materials Inc. (company) — Filer of the 8-K
• November 12, 2024 (date) — Date of earliest event reported
• 001-36285 (other) — SEC File Number

FAQ

Key Financial Figures

• $0.01 — nge on which Registered Common Stock, $0.01 par value RYAM New York Stock Excha

Filing Documents

• ef20038813_8k.htm (8-K) — 28KB
• ef20038813_ex99-1.htm (EX-99.1) — 11KB
• image00001.jpg (GRAPHIC) — 452KB
• image00002.jpg (GRAPHIC) — 4KB
• 0001140361-24-047175.txt ( ) — 1321KB
• ryam-20241112.xsd (EX-101.SCH) — 4KB
• ryam-20241112_lab.xml (EX-101.LAB) — 21KB
• ryam-20241112_pre.xml (EX-101.PRE) — 16KB
• ef20038813_8k_htm.xml (XML) — 4KB

01

Item 1.01. Entry Into a Material Definitive Agreement On November 12, 2024, RYAM BioNova SAS, a French simplified joint-stock company ("RYAM BioNova SAS"), as Borrower, and Rayonier A.M. France SAS, a French simplified joint-stock company ("RYAM France"), as Guarantor, each subsidiaries of Rayonier Advanced Materials Inc. ("RYAM") entered into a Senior Credit Loan Agreement for 37 million in secured term loans with Crdit Lyonnais, Arka Banque Entreprises et Institutionnels, and BNP Paribas (the "Credit Agreement"). The Credit Agreement establishes a credit facility of EUR 37,000,000, divided into Tranche A, totaling EUR 27,750,000, and Tranche B, totaling EUR 9,250,000. Borrowings under the facility bear interest at a floating rate tied to EURIBOR, with an initial margin of 2.00% per annum for Tranche A and 2.50% per annum for Tranche B, subject to adjustment based on certain financial performance metrics. Tranche A requires quarterly principal repayments commencing February 12, 2027, with each installment amounting to 5% of the drawn amount, and the outstanding balance to be fully repaid by the final maturity date of November 12, 2031. Tranche B is structured with a single balloon repayment at its maturity date on November 12, 2032. Drawdowns are available under the Credit Agreement until the second anniversary of the Credit Agreement, subject to customary conditions precedent. On November 12, 2024, RYAM France, RYAM, RYAM BioNova SAS and SWEN Impact Fund for Transition 3 ("SWEN") entered into the RYAM BioNova Shareholder Agreement (the "Shareholder Agreement") in connection with SWEN's equity investment in RYAM BioNova SAS, which contemplates that SWEN will fund up to 30 million in exchange for preferred shares representing a 20% ownership stake RYAM BioNova SAS. Of this commitment, 15 million is to be funded at closing, with subsequent funding of the balance to be made contingent on achievement of key RYAM BioNova SAS project milestones. As the holder of the

01

Item 7.01. Regulation FD Disclosure RYAM issued a press release announcing the Credit Agreement and SWEN's equity investment in RYAM BioNova SAS. A copy of the press release announcing the debt and equity transactions is furnished herewith as Exhibit 99.1.

Financial Statements and Exhibits

Financial Statements and Exhibits 99.1 Press release entitled " RYAM Raises 67 million Green Capital to Invest in its Biomaterials Strategy" 104 Cover page interactive data file (embedded within the Inline XBRL document) 1 Signature Pursuant to the requirements of the Securities Exchange Act of l934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Rayonier Advanced Materials Inc. By: /s/ R. COLBY SLAUGHTER R. Colby Slaughter Senior Vice President, General Counsel and Corporate Secretary Date: November 18, 2024

View Full Filing

View this 8-K filing on SEC EDGAR